Long-segment SFA stenting - The dark sides: In-stent restenosis, clinical deterioration, and stent fractures

Journal of Endovascular Therapy

Volumn 12, Issue 6, 2005, Pages 676-684

  Schlager, Oliver ^a   Dick, Petra ^a   Sabeti, Schila ^a   Amighi, Jasmin ^a   Mlekusch, Wolfgang ^a   Minar, Erich ^a   Schillinger, Martin ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Nitinol stent; Peripheral artery disease; Restenosis; Stent fracture; Stents; Superficial femoral artery

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CLAUDICATION; DETERIORATION; DEVICE; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSTHESIS FAILURE; RADIOGRAPHY; RESTENOSIS; SMOKING; STATISTICAL ANALYSIS; STENT; STENT FRACTURE; STROKE; SUPERFICIAL FEMORAL ARTERY;

ADULT; AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; HUMANS; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSTHESIS FAILURE; RECURRENCE; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 30744433628     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/05-1672.1     Document Type: Article

References (16)

1. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
3. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
4. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83:170-80.
5. Cejna M, Turnher S, Illiasch H, et al. PTA versus Palmaz stent in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
6. Vroegineweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
7. Grimm J, Muller-Hulsbeck S, Jahnke T, et al. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-942.
8. Zdanowski Z, Albrechtsson U, Lundin A, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18:251-255.
9. Becquemin JP, Favre JP, Marzelle J, et al. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487-494.
10. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
11. Sabeti S, Amighi J, Ahmadi R, et al. Outcome of long-segment femoropopliteal stent implantation using self-expanding nitinol stents. J Endovasc Ther. 2005;12:6-12.
12. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology. 2002;222:37-43.
13. Sabeti S, Schillinger M, Amighi J, at al. Patency of nitinol vs. Wallstents in the superficial femoral artery - a propensity score adjusted analysis. Radiology. 2004;232:516-521.
14. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16: 331-338.
15. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315.
16. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992; 18:433-440.